International Biotechnology Trust’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $13.6M | Buy |
153,656
+95,000
| +162% | +$8.41M | 4.58% | 5 |
|
|
2023
Q2 | $5.08M | Hold |
58,656
| – | – | 1.55% | 23 |
|
|
2023
Q1 | $5.7M | Buy |
58,656
+15,000
| +34% | +$1.46M | 1.59% | 23 |
|
|
2022
Q4 | $4.51M | Sell |
43,656
-15,000
| -26% | -$1.55M | 1.39% | 23 |
|
|
2022
Q3 | $4.97M | Buy |
58,656
+52,055
| +789% | +$4.41M | 1.59% | 20 |
|
|
2022
Q2 | $79.7K | Sell |
6,601
-73,055
| -92% | -$882K | 0.83% | 29 |
|
|
2022
Q1 | $235K | Sell |
79,656
-25,500
| -24% | -$75.2K | 0.05% | 67 |
|
|
2021
Q4 | $9.29M | Buy |
105,156
+50,000
| +91% | +$4.42M | 2.07% | 19 |
|
|
2021
Q3 | $4.26M | Hold |
55,156
| – | – | 1.03% | 28 |
|
|
2021
Q2 | $4.6M | Hold |
55,156
| – | – | 1.22% | 23 |
|
|
2021
Q1 | $4.17M | Sell |
55,156
-192,428
| -78% | -$14.5M | 1.1% | 24 |
|
|
2020
Q4 | $21.7M | Hold |
247,584
| – | – | 5.92% | 4 |
|
|
2020
Q3 | $18.8M | Buy |
247,584
+62,000
| +33% | +$4.71M | 6.07% | 5 |
|
|
2020
Q2 | $22.7M | Buy |
185,584
+15,800
| +9% | +$1.93M | 7.54% | 2 |
|
|
2020
Q1 | $14.3M | Buy |
169,784
+65,500
| +63% | +$5.53M | 6.54% | 4 |
|
|
2019
Q4 | $8.81M | Buy |
104,284
+17,000
| +19% | +$1.44M | 3.18% | 11 |
|
|
2019
Q3 | $5.88M | Buy |
87,284
+23,000
| +36% | +$1.55M | 2.72% | 15 |
|
|
2019
Q2 | $5.51M | Hold |
64,284
| – | – | 2.04% | 17 |
|
|
2019
Q1 | $5.7M | Sell |
64,284
-28,000
| -30% | -$2.48M | 2.11% | 18 |
|
|
2018
Q4 | $6.18M | Sell |
92,284
-5,000
| -5% | -$335K | 3.83% | 9 |
|
|
2018
Q3 | $7.23M | Hold |
97,284
| – | – | 3.44% | 11 |
|
|
2018
Q2 | $9.16M | Buy |
97,284
+32,000
| +49% | +$3.01M | 3.52% | 11 |
|
|
2018
Q1 | $5.29M | Sell |
65,284
-3,100
| -5% | -$251K | 2.06% | 18 |
|
|
2017
Q4 | $6.1M | Hold |
68,384
| – | – | 2.15% | 18 |
|
|
2017
Q3 | $6.36M | Sell |
68,384
-49,782
| -42% | -$4.63M | 2.48% | 11 |
|
|
2017
Q2 | $10.7M | Buy |
118,166
+40,500
| +52% | +$3.68M | 4.08% | 6 |
|
|
2017
Q1 | $6.82M | Buy |
77,666
+2,000
| +3% | +$176K | 2.61% | 12 |
|
|
2016
Q4 | $6.27M | Buy |
+75,666
| New | +$6.27M | 2.82% | 14 |
|